NORD — Nordicus Partners Corp
—
OTC ·
Unknown ·
Unknown ·
CIK 1011060 ·
Last close
$4.01
Market Cap
$75.74M
52W High
$4.18
52W Low
$2.21
ADV30
1,690
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -1,122,172 | -1,227,214 | 75,856,649 | 189,297 | 11,106,028 |
| Sep 2025 | 0 | — | -1,211,478 | -1,511,474 | 75,882,821 | 242,155 | 11,215,508 |
| Jun 2025 | 0 | — | -831,886 | -1,206,886 | 76,124,458 | 8,418 | 11,863,490 |
| Mar 2025 | 0 | — | -888,491 | -606,404 | 70,246,329 | 19,914 | 10,381,075 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,034,797
Investing CF
$-20,391
Financing CF
$4,142,049
CapEx
$-8,762
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-50,730,422
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-3,896,905
Pretax Income TTM
$-4,572,288
Interest Exp TTM
$389
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-4,048,815
Free Cash Flow
$-2,762,971
Enterprise Value
$76,055,104
Total Cash
$189,297
Total Debt
$0
Shares Out
18,888,396
Trailing EPS
$-0.19
Book Value
$3.44
ROE
-7.4%
ROA
-3.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 5,000 | -2,919,365 | -2,901,321 | 70,246,329 | 10,381,075 | — | -1,284,615 |
| Mar 2024 | 2,500 | -307,588 | -298,202 | 1,807,573 | 26,405 | — | -258,928 |
| Mar 2023 | 0 | -8,479,889 | -8,472,216 | 55,025 | 27,367 | — | -368,347 |
TTM Snapshot
Revenues TTM
$2,299,000
NetIncome TTM
$-359,000
OpCashFlow TTM
$0
Assets (Latest)
$2,432,000
Forward EPS
—
News headlines (Yahoo Finance, 1h cache)
Nordicus Partners Corporation Corporate Update
2026-02-06 16:55 · Yahoo
NoviThera has initiated the first efficacy animal studies
2025-11-13 16:00 · Yahoo
Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.
2025-10-22 13:00 · Yahoo
Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
2025-10-20 13:00 · Yahoo
Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS
2025-10-03 20:38 · Yahoo
Nordicus Partners Corporation Applies to Uplist to the Nasdaq Capital Market
2025-09-02 13:53 · Yahoo
Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors
2025-08-07 13:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.